Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2020

Open Access 01-12-2020 | Diabetes | Research article

Leu72Met polymorphism of GHRL gene decreases susceptibility to type 2 diabetes mellitus in a Mexican population

Authors: Edgar Alfonso Rivera-León, Mara Anaís Llamas-Covarrubias, Sergio Sánchez-Enríquez, Erika Martínez-López, Mercedes González-Hita, Iris Monserrat Llamas-Covarrubias

Published in: BMC Endocrine Disorders | Issue 1/2020

Login to get access

Abstract

Background

Type 2 diabetes mellitus (T2D) is the most frequent type of diabetes. It has a multifactorial etiology, affecting millions of people worldwide. Ghrelin gene (GHRL) encodes the ghrelin peptide, which promotes food intake, induces body weight and adipogenesis. Several single nucleotide polymorphisms (SNPs) in GHRL gene have been associated with metabolic diseases. A protective effect of the Leu72Met (rs696217) polymorphism has been described for T2D in some populations, but this effect seems to depend on the ethnicity of the patients studied.

Methods

The aim of this study was to investigate the association between the GHRL Leu72Met (rs696217) SNP with the development of T2D and serum ghrelin levels in a Western Mexican population. We performed a case-control study in which we included 284 subjects (159 with previous T2D diagnosis and 125 control subjects (CS)). Leu72Met SNP was genotyped by using PCR-RFLPs technique. Serum ghrelin levels were measured using a commercial enzyme immunoassay. Genotypic and allelic distributions were compared using Chi square test. Student T-test and Mann-Whitney U test were used to compare quantitative variables. Odds ratio (OR) was used to evaluate the association between alleles or genotypes and T2D. Multiple and logistic regression models were performed for adjustment. A two-tailed p-value ≤0.05 was considered statistically significant.

Results

Leu72Leu genotype was more frequent among T2D compared to CS (p < 0.05). After adjusting for age and body composition, there was a significant protective effect of the 72Met allele for T2D development (OR 0.40 IC 95% 0.23–0.70; p ≤ 0.001). Fasting serum ghrelin levels were lower in T2D than CS (p ≤ 0.0001) irrespective of age, body weight and BMI. No associations were found between genotypes and ghrelin serum levels in our population.

Conclusions

The GHRL 72Met allele decreases susceptibility for T2D development in a Western Mexican population. Serum ghrelin levels are lower in T2D independently of Leu72Met polymorphism genotype.
Literature
1.
go back to reference Alam U, Asghar O, Azmi S, Malik RA. General aspects of diabetes mellitus. Handb Clin Neurol. 2014;126:211–22.CrossRef Alam U, Asghar O, Azmi S, Malik RA. General aspects of diabetes mellitus. Handb Clin Neurol. 2014;126:211–22.CrossRef
3.
go back to reference Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.CrossRef Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.CrossRef
5.
6.
go back to reference Meza R, Barrientos-Gutierrez T, Rojas-Martinez R, Reynoso-Noverón N, Palacio-Mejia LS, Lazcano-Ponce E, et al. Burden of type 2 diabetes in Mexico: past, current and future prevalence and incidence rates. Prev Med. 2015;81:445–50.CrossRef Meza R, Barrientos-Gutierrez T, Rojas-Martinez R, Reynoso-Noverón N, Palacio-Mejia LS, Lazcano-Ponce E, et al. Burden of type 2 diabetes in Mexico: past, current and future prevalence and incidence rates. Prev Med. 2015;81:445–50.CrossRef
7.
go back to reference la Cruz-Góngora VD, Martínez-Tapia B, Cuevas-Nasu L, Flores-Aldana M, Shamah-Levy T. Dietary intake and adequacy of energy and nutrients in Mexican older adults: results from two National Health and nutrition surveys. Salud Publica Mex. 2017;59(3):285–98.CrossRef la Cruz-Góngora VD, Martínez-Tapia B, Cuevas-Nasu L, Flores-Aldana M, Shamah-Levy T. Dietary intake and adequacy of energy and nutrients in Mexican older adults: results from two National Health and nutrition surveys. Salud Publica Mex. 2017;59(3):285–98.CrossRef
8.
go back to reference Gaona-Pineda EB, Mejía-Rodríguez F, Cuevas-Nasu L, Gómez-Acosta LM, Rangel-Baltazar E, Flores-Aldana ME. Dietary intake and adequacy of energy and nutrients in Mexican adolescents: results from Ensanut 2012. Salud Publica Mex. 2018;60(4):404–13.CrossRef Gaona-Pineda EB, Mejía-Rodríguez F, Cuevas-Nasu L, Gómez-Acosta LM, Rangel-Baltazar E, Flores-Aldana ME. Dietary intake and adequacy of energy and nutrients in Mexican adolescents: results from Ensanut 2012. Salud Publica Mex. 2018;60(4):404–13.CrossRef
9.
go back to reference López-Olmedo N, Carriquiry AL, Rodríguez-Ramírez S, Ramírez-Silva I, Espinosa-Montero J, Hernández-Barrera L, et al. Usual intake of added sugars and saturated fats is high while dietary Fiber is low in the Mexican population. J Nutr. 2016;146(9):1856S–65S.CrossRef López-Olmedo N, Carriquiry AL, Rodríguez-Ramírez S, Ramírez-Silva I, Espinosa-Montero J, Hernández-Barrera L, et al. Usual intake of added sugars and saturated fats is high while dietary Fiber is low in the Mexican population. J Nutr. 2016;146(9):1856S–65S.CrossRef
11.
go back to reference Choi HJ, Cho YM, Moon MK, Choi HH, Shin HD, Jang HC, et al. Polymorphisms in the Ghrelin Gene Are Associated with Serum High-Density Lipoprotein Cholesterol Level and not with Type 2 Diabetes Mellitus in Koreans. None. 2006;91(11):4657–63. Choi HJ, Cho YM, Moon MK, Choi HH, Shin HD, Jang HC, et al. Polymorphisms in the Ghrelin Gene Are Associated with Serum High-Density Lipoprotein Cholesterol Level and not with Type 2 Diabetes Mellitus in Koreans. None. 2006;91(11):4657–63.
12.
go back to reference Poher A-L, Tschöp MH, Müller TD. Ghrelin regulation of glucose metabolism. Peptides. 2018;100:236–42.CrossRef Poher A-L, Tschöp MH, Müller TD. Ghrelin regulation of glucose metabolism. Peptides. 2018;100:236–42.CrossRef
13.
go back to reference Berthold HK, Giannakidou E, Krone W, Mantzoros CS, Gouni-Berthold I. The Leu72Met polymorphism of the ghrelin gene is associated with a decreased risk for type 2 diabetes. Clin Chim Acta. 2009;399(1–2):112–6.CrossRef Berthold HK, Giannakidou E, Krone W, Mantzoros CS, Gouni-Berthold I. The Leu72Met polymorphism of the ghrelin gene is associated with a decreased risk for type 2 diabetes. Clin Chim Acta. 2009;399(1–2):112–6.CrossRef
14.
go back to reference Liao N, Xie Z-K, Huang J, Xie Z-F. Association between the ghrelin Leu72Met polymorphism and type 2 diabetes risk: a meta-analysis. Gene. 2013;517(2):179–83.CrossRef Liao N, Xie Z-K, Huang J, Xie Z-F. Association between the ghrelin Leu72Met polymorphism and type 2 diabetes risk: a meta-analysis. Gene. 2013;517(2):179–83.CrossRef
15.
go back to reference Gueorguiev M, Lecoeur C, Meyre D, Benzinou M, Mein CA, Hinney A, et al. Association studies on ghrelin and ghrelin receptor gene polymorphisms with obesity. Obesity. 2009;17(4):745–54.CrossRef Gueorguiev M, Lecoeur C, Meyre D, Benzinou M, Mein CA, Hinney A, et al. Association studies on ghrelin and ghrelin receptor gene polymorphisms with obesity. Obesity. 2009;17(4):745–54.CrossRef
17.
go back to reference Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.CrossRef Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.CrossRef
18.
go back to reference Serra-Prat M, Fernández X, Burdoy E, Mussoll J, Casamitjana R, Puig-Domingo M, et al. The role of ghrelin in the energy homeostasis of elderly people: a population-based study. J Endocrinol Invest. 2007;30(6):484–90.CrossRef Serra-Prat M, Fernández X, Burdoy E, Mussoll J, Casamitjana R, Puig-Domingo M, et al. The role of ghrelin in the energy homeostasis of elderly people: a population-based study. J Endocrinol Invest. 2007;30(6):484–90.CrossRef
19.
go back to reference Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001;50(4):707–9.CrossRef Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001;50(4):707–9.CrossRef
20.
go back to reference Gómez-Díaz RA, Gómez-Medina MP, Ramírez-Soriano E, López-Robles L, Aguilar-Salinas CA, Saucedo R, et al. Lower Plasma Ghrelin Levels are Found in Women with Diabetes-Complicated Pregnancies. J Clin Res Pediatr Endocrinol. 2016;8(4):425–31.CrossRef Gómez-Díaz RA, Gómez-Medina MP, Ramírez-Soriano E, López-Robles L, Aguilar-Salinas CA, Saucedo R, et al. Lower Plasma Ghrelin Levels are Found in Women with Diabetes-Complicated Pregnancies. J Clin Res Pediatr Endocrinol. 2016;8(4):425–31.CrossRef
21.
go back to reference Ukkola O, Pöykkö SM, Antero KY. Low plasma ghrelin concentration is an indicator of the metabolic syndrome. Ann Med. 2006;38(4):274–9.CrossRef Ukkola O, Pöykkö SM, Antero KY. Low plasma ghrelin concentration is an indicator of the metabolic syndrome. Ann Med. 2006;38(4):274–9.CrossRef
22.
go back to reference Al Qarni AA, Joatar FE, Das N, Awad M, Eltayeb M, Al-Zubair AG, et al. Association of Plasma Ghrelin Levels with Insulin Resistance in Type 2 Diabetes Mellitus among Saudi Subjects. Endocrinol Metab (Seoul). 2017;32(2):230–40.CrossRef Al Qarni AA, Joatar FE, Das N, Awad M, Eltayeb M, Al-Zubair AG, et al. Association of Plasma Ghrelin Levels with Insulin Resistance in Type 2 Diabetes Mellitus among Saudi Subjects. Endocrinol Metab (Seoul). 2017;32(2):230–40.CrossRef
23.
go back to reference Tong J, Prigeon RL, Davis HW, Bidlingmaier M, Kahn SE, Cummings DE, et al. Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans. Diabetes. 2010;59(9):2145–51.CrossRef Tong J, Prigeon RL, Davis HW, Bidlingmaier M, Kahn SE, Cummings DE, et al. Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans. Diabetes. 2010;59(9):2145–51.CrossRef
24.
go back to reference Sun Y, Asnicar M, Saha PK, Chan L, Smith RG. Ablation of ghrelin improves the diabetic but not obese phenotype of Ob/Ob mice. Cell Metab. 2006;3(5):379–86.CrossRef Sun Y, Asnicar M, Saha PK, Chan L, Smith RG. Ablation of ghrelin improves the diabetic but not obese phenotype of Ob/Ob mice. Cell Metab. 2006;3(5):379–86.CrossRef
25.
go back to reference Bing C, Ambye L, Fenger M, Jørgensen T, Borch-Johnsen K, Madsbad S, et al. Large-scale studies of the Leu72Met polymorphism of the ghrelin gene in relation to the metabolic syndrome and associated quantitative traits. Diabet Med. 2005;22(9):1157–60.CrossRef Bing C, Ambye L, Fenger M, Jørgensen T, Borch-Johnsen K, Madsbad S, et al. Large-scale studies of the Leu72Met polymorphism of the ghrelin gene in relation to the metabolic syndrome and associated quantitative traits. Diabet Med. 2005;22(9):1157–60.CrossRef
26.
go back to reference Zavarella S, Petrone A, Zampetti S, Gueorguiev M, Spoletini M, Mein CA, et al. A new variation in the promoter region, the −604 C>T, and the Leu72Met polymorphism of the ghrelin gene are associated with protection to insulin resistance. Int J Obes (Lond). 2008;32(4):663–8.CrossRef Zavarella S, Petrone A, Zampetti S, Gueorguiev M, Spoletini M, Mein CA, et al. A new variation in the promoter region, the −604 C>T, and the Leu72Met polymorphism of the ghrelin gene are associated with protection to insulin resistance. Int J Obes (Lond). 2008;32(4):663–8.CrossRef
27.
go back to reference Li Y-Y, Lu X-Z, Yang X-X, Wang H, Geng H-Y, Gong G, et al. GHRL gene Leu72Met polymorphism and type 2 diabetes mellitus: a meta-analysis involving 8,194 participants. Front Endocrinol. 2019;10:559. Li Y-Y, Lu X-Z, Yang X-X, Wang H, Geng H-Y, Gong G, et al. GHRL gene Leu72Met polymorphism and type 2 diabetes mellitus: a meta-analysis involving 8,194 participants. Front Endocrinol. 2019;10:559.
28.
go back to reference Kim S-Y, Jo D-S, Hwang PH, Park JH, Park SK, Yi HK, et al. Preproghrelin Leu72Met polymorphism is not associated with type 2 diabetes mellitus. Metabolism. 2006;55(3):366–70.CrossRef Kim S-Y, Jo D-S, Hwang PH, Park JH, Park SK, Yi HK, et al. Preproghrelin Leu72Met polymorphism is not associated with type 2 diabetes mellitus. Metabolism. 2006;55(3):366–70.CrossRef
29.
go back to reference Ukkola O, Ravussin E, Jacobson P, Pérusse L, Rankinen T, Tschöp M, et al. Role of ghrelin polymorphisms in obesity based on three different studies. Obes Res. 2002;10(8):782–91.CrossRef Ukkola O, Ravussin E, Jacobson P, Pérusse L, Rankinen T, Tschöp M, et al. Role of ghrelin polymorphisms in obesity based on three different studies. Obes Res. 2002;10(8):782–91.CrossRef
30.
go back to reference Kuzuya M, Ando F, Iguchi A, Shimokata H. Preproghrelin Leu72Met variant contributes to overweight in middle-aged men of a Japanese large cohort. Int J Obes (Lond). 2006;30(11):1609–14.CrossRef Kuzuya M, Ando F, Iguchi A, Shimokata H. Preproghrelin Leu72Met variant contributes to overweight in middle-aged men of a Japanese large cohort. Int J Obes (Lond). 2006;30(11):1609–14.CrossRef
31.
go back to reference Miraglia del Giudice E, Santoro N, Cirillo G, Raimondo P, Grandone A, D’Aniello A, et al. Molecular screening of the ghrelin gene in Italian obese children: the Leu72Met variant is associated with an earlier onset of obesity. Int J Obes Relat Metab Disord. 2004;28(3):447–50.CrossRef Miraglia del Giudice E, Santoro N, Cirillo G, Raimondo P, Grandone A, D’Aniello A, et al. Molecular screening of the ghrelin gene in Italian obese children: the Leu72Met variant is associated with an earlier onset of obesity. Int J Obes Relat Metab Disord. 2004;28(3):447–50.CrossRef
32.
go back to reference Huang T, Shu Y, Cai Y-D. Genetic differences among ethnic groups. BMC Genomics. 2015;16:1093.CrossRef Huang T, Shu Y, Cai Y-D. Genetic differences among ethnic groups. BMC Genomics. 2015;16:1093.CrossRef
Metadata
Title
Leu72Met polymorphism of GHRL gene decreases susceptibility to type 2 diabetes mellitus in a Mexican population
Authors
Edgar Alfonso Rivera-León
Mara Anaís Llamas-Covarrubias
Sergio Sánchez-Enríquez
Erika Martínez-López
Mercedes González-Hita
Iris Monserrat Llamas-Covarrubias
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2020
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-020-00596-3

Other articles of this Issue 1/2020

BMC Endocrine Disorders 1/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.